Health

FDA Plan Provides Emergency Authorization to Treat Coronavirus Patients

As a result of pressure from the Trump administration to move forward more quickly for a remedy, the Food and Drug Administration has developed an emergency authorization strategy to treat Covid-19 patients with convalescent plasma.
The convalescent plasma, which is made using blood from people who have recovered from coronavirus infections, has been used to treat more than 70,000 Covid-19 patients. FDA findings also state that the “known and potential benefits of the product outweigh the known and potential risks.”
While trials continue to be underway, early studies have also shown promise despite arguments by some health experts that data from randomized, placebo-controlled clinical trials are needed before it can be determined that the treatment is effective against Covid-19.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker